Join us for a panel discussion on 18th January 2022 at 2pm – 3pm (CET) following the release of the IQVIA report on Understanding Net Pharmaceutical Expenditure Dynamics in Europe which, for the first time, offers estimates of total drug spending, including hospitals and net of discounts and rebates across 15 European countries. This is a follow-on from the multistakeholder discussion held with academic institutions by the IQVIA Institute for Human Data Science on the net expenditure for eleven global markets in 2021. The report also explains the drivers of change in drug expenditure over time and the dynamic composition by therapy area. 

Topics for discussion:
•     Trends in healthcare spending and medicine spending since 2000, variability, net-level growth, and convergence
•     Understanding the drivers of growth in drug expenditure and relative importance of newly launched drugs, pricing and volume changes over time, and post-exclusivity dynamics
•     Therapy area dynamics, contrasting high expenditure areas across a 20-year period and the evolution over time
•     The importance of understanding medicine spending in context and relevance to current policy discussions
•     Implications of drug expenditure dynamics for stakeholders budgeting for future innovation